J Nanobiotechnology. 2026 Feb 13.doi: 10.1186/s12951-026-04109-7.
2026-02-13J Nanobiotechnology. 2026 Feb 13.doi: 10.1186/s12951-026-04109-7. T7 peptide-engineered liposomal Irisin mitigates PND progression through AMPK/PGC-1α signaling: multi-omic evidence of metabolic and epigenetic modulation